ETFs United Therapeutics Corporation

Equities

UTHR

US91307C1027

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2024-07-16 EDT 5-day change 1st Jan Change
328.2 USD +0.28% Intraday chart for United Therapeutics Corporation +1.72% +49.25%

ETFs positioned on United Therapeutics Corporation

Name Weight AuM 1st Jan change Investor Rating
3.06% 1 M€ +4.87% -
2.87% 2 M€ +7.73%
1.55% 7 M€ +2.93%
1.46% 1,184 M€ +12.12% -
1.18% 0 M€ 0.00% -
0.95% 0 M€ 0.00% -
0.60% 12 M€ -.--% -
0.22% 379 M€ +13.84%
0.13% 9 M€ -.--% -
0.13% 13 M€ -.--% -
0.13% 3 M€ +7.32% -
0.13% 1 M€ +11.94% -
0.12% 9 M€ +16.85% -
0.07% 31 M€ +2.82% -
0.07% 20 M€ +9.50% -
0.07% 8 M€ +9.50% -
0.06% 825 M€ +16.39%
0.06% 9 M€ +13.96% -
0.06% 330 M€ -.--% -
0.04% 1 M€ +0.04%
0.04% 10 M€ +15.73%
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
328.2 USD
Average target price
314.5 USD
Spread / Average Target
-4.18%
Consensus
  1. Stock Market
  2. Equities
  3. UTHR Stock
  4. ETFs United Therapeutics Corporation